Geron stock opened at $1.64 on Wednesday. Geron has a 1-year low of $1.46 and a 1-year high of $5.34. The firm has a market capitalization of $1.04 billion, a price-to-earnings ratio of -5.13 and ...

SAN DIEGO, March 14, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Geron Corporation (NASDAQ ...

Geron Trading Down 1.8 % NASDAQ:GERN opened at $1.64 on Monday. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.74 and a current ratio of 2.89. The firm has a market cap of $1. ...

Geron is also testing the drug for myelofibrosis (MF), another form of bone marrow cancer, and expects data from the phase 3 IMpactMF trial of imetelstat in relapsed/refractory MF in 2024.

resulting in an inability for Geron to capitalize on the purportedly significant unmet need for the drug, particularly among first-line patients and those outside the academic setting. The ...

Geron's first-in-class cancer drug Rytelo, recently approved by the FDA for myelodysplastic syndromes (MDS), is priced three to four times higher than it should be, according to the Institute for ...

Les 27 ministres des Affaires étrangères de l’Union Européenne (UE) sont réunis à Bruxelles ce lundi 17 mars avec en ...

Pourtant, cela coûte plus cher de se faire soigner aujourd'hui, pour 2 raisons principales. D'une part, les cotisations des complémentaires santé ne cessent d'augmenter. D'autre part ...

Le standard IEEE 802.1Q fournit un mécanisme d'encapsulation très répandu et implanté dans de nombreux équipements de marques différentes, aussi bien que dans les commutateurs réseau virtuels de ...